Sign in
4

Changes in Ownership

MBX Biosciences, Inc. Filed Acc 0001193125-26-214574

President & CEO sold 607 shares at $29.54 ($17,931)

From the SEC's structured data for this filing

Trades in this filing

Hawryluk P. Kent · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-06 Sale : show line 1 in the form −607 $29.54 $17,931 727,667 D
Open-market sales · 607 sh · avg $29.54 · $17,931
Loading xslF345X06/ownership.xml…